We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Criticizes Submission Quality As User Fee Talks Progress
FDA Criticizes Submission Quality As User Fee Talks Progress
February 11, 2011
The FDA is pushing industry to address “chronic quality problems” with 510(k) and PMA submissions to improve review times, as negotiations begin on the Medical Device User Fee and Modernization Act (MDUFMA) reauthorization.